Back to Search
Start Over
Study Findings on Cancer Imaging Described by Researchers at Tehran University of Medical Sciences (Development of novel radiolabeled antibody-conjugated graphene quantum dots for targeted in vivo breast cancer imaging and biodistribution...).
- Source :
- Women's Health Weekly; 2/16/2024, p1206-1206, 1p
- Publication Year :
- 2024
-
Abstract
- A recent study conducted by researchers at Tehran University of Medical Sciences in Iran explores the development of a novel radiolabeled antibody-conjugated graphene quantum dots for targeted breast cancer imaging and biodistribution. Nanotechnology-based drug delivery platforms have shown promise in the diagnosis and treatment of cancers, and nanoparticle-antibody conjugates have been developed for tumor imaging and immunoassays. The researchers utilized graphene quantum dots conjugated with pembrolizumab, a human monoclonal antibody, to create a breast cancer imaging probe. The probe was radiolabeled with Technetium-99m and demonstrated high activity at the tumor site, suggesting its potential as a novel probe for radiopharmaceutical-based immune checkpoint monoclonal antibodies and immunotherapy for various cancers. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 10787240
- Database :
- Supplemental Index
- Journal :
- Women's Health Weekly
- Publication Type :
- Periodical
- Accession number :
- 175339950